Drugs from Ionis and Arrowhead Pharma that block ... and ultra-rare disorder familial chylomicronaemia syndrome (FCS). At ACC, Ionis reported results from the phase 3 BALANCE trial of its ...

Researchers have uncovered a promising therapeutic target for adenoid cystic carcinoma (ACC), a rare cancer of the salivary ...

While marijuana has been legalized in many states, research has shown that it could have detrimental health impacts for some ...

Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...

Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis are more likely to suffer ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the ...

With marijuana becoming legal in more states, doctors want users to be more transparent with their usage as risks like heart ...

The Prime Minister will use the budget to try to bribe his way back to office but stop and consider everything that’s going ...

Under federal law, device makers must submit adverse event reports they receive from patients to the FDA’s Manufacturer And ...

A patient has died while taking a closely watched gene therapy for muscular dystrophy. Sarepta Therapeutics announced the death Tuesday morning, sending the company's shares plummeting in morning ...

Some gonorrhoea infections have become untreatable with all seven main antibiotic classes – a situation last encountered in the 1920s, before the advent of effective drugs for the bacterium.

Two new studies add to mounting evidence that people who use cannabis are more likely to suffer a heart attack than people who do not use the drug, even among younger ... Cardiology's Annual ...